High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova

Eur Respir J. 2017 Oct 12;50(4):1701340. doi: 10.1183/13993003.01340-2017. Print 2017 Oct.

Dumitru Chesov^{1

2}, Nelly Ciobanu^{3

2}, Christoph Lange^{4

5

6}, Jan Heyckendorf⁴, Valeriu Crudu³

¹ Dept of Pneumology and Allergology, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chişinău, Republic of Moldova dumitru.chesov@usmf.md.
² These authors contributed equally.
³ National TB Reference Laboratory, Phthisiopneumology Institute "Chiril Draganiuc", Chişinău, Republic of Moldova.
⁴ Division of Clinical Infectious Diseases, German Center for Infection Research (DZIF), Research Center Borstel, Borstel, Germany.
⁵ International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.
⁶ Dept of Medicine, Karolinska Institute, Stockholm, Sweden.

No abstract available

Publication types